Tag: Altitude Investment Management
You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
Exclusive Interview with Altitude Investment Management Partner Roderick Stephan Altitude Investment Management’s first cannabis fund includes a diverse collection of companies across multiple verticals. Now, the company is raising...
Canndescent Closes $27.5 Million Series C Preferred Funding The investment will fuel Canndescent’s new product categories and drive regional expansion SANTA BARBARA, CA – September 10, 2019 – Canndescent,...
BDS Analytics Announces $10 Million Fundraise as Global Cannabis Markets Expand and Diversify BOULDER, Colo., Aug. 20, 2019 /PRNewswire/ — BDS Analytics, the leader in comprehensive, actionable, and accurate...
Altitude Investment Management Closes Cannabis Fund I at $30M NYC Based Cannabis Investment Firm Successful Fund I Raise, looks to Fund II NEW YORK––(November 27, 2018) Altitude Investment Management,...
This is a copy of the October 28th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, What a difference a week makes. Just...
Brandon David of Investing in Cannabis talked with Jon Trauben of Altitude Investments, a venture-capital fund based in New York that invests in early-stage and growth companies in the...
Front Range Biosciences Raises $10 Million in Series A Financing Leading agricultural biotech company closes largest ever U.S. cannabis biotech funding round BOULDER, Colo., Oct. 4, 2018 /PRNewswire/ —...
Altitude Investment Management Updates Its Cannabis Fund’s Holdings with $23.8 Million in Raised Capital Ten New Investments Since Initial March 2018 Fund Close September 11, 2018 (New York) ––...
Canndescent Closes $13m Series C Convertible Note to Expand Its Product Portfolio, Initiate Expansion Into Other States, and Roll Out New Brands. Santa Barbara, September 6, 2018—CANNDESCENT, California’s leading...
DNA-Based Pathogen Testing Company PathogenDx Raises $3.4 Million in Convertible Note Round July 17, 2018 – Tucson, AZ – PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology...
Cannabis Data Leader, BDS Analytics, Raises $3.5 Million in Series B Led by CanopyVentures and Altitude Investment Management BOULDER, Colo., May 17, 2018 /PRNewswire/ — BDS Analytics, the leader...
Altitude Investment Management Closes $18.7M for Cannabis Investment Fund NYC Based Venture Capital Firm to Raise $50M to Expand Cannabis Portfolio April 10, 2018 (New York) — Altitude Investment...